Revolution Medicines
RVMD
RVMD
184 hedge funds and large institutions have $4.64B invested in Revolution Medicines in 2023 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 81 increasing their positions, 34 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
184
Holders Change
+16
Holders Change %
+9.52%
% of All Funds
2.7%
Holding in Top 10
13
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+44.44%
% of All Funds
0.19%
New
54
Increased
81
Reduced
34
Closed
36
Calls
$19.1M
Puts
$10.2M
Net Calls
+$8.88M
Net Calls Change
+$5.64M
Top Buyers
| 1 |
AI
Alphabet Inc
Mountain View,
California
|
$152M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
$420M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
$427M |
| 4 |
BlackRock
New York
|
$372M |
| 5 |
CC
Casdin Capital
New York
|
$164M |
Top Sellers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
$3.8M |
| 2 |
CG
Column Group
San Francisco,
California
|
$1.32K |
| 3 |
AG
Artal Group
Luxembourg
|
$48.6M |
| 4 |
D.E. Shaw & Co
New York
|
$1.46M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
$1.72M |
